or Try an Advanced Search...

    Technical Analysis for AUTL - Autolus Therapeutics plc

    Grade Last Price % Change Price Change
    F 4.11 2.49% 0.10
    AUTL closed up 2.49 percent on Wednesday, May 8, 2024, on approximately normal volume.
    Earnings due: May 14
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical AUTL trend table...
    Date Alert Name Type % Chg
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    NR7 Range Contraction 2.49%
    Wide Bands Range Expansion 2.49%
    MACD Bullish Signal Line Cross Bullish 0.74%
    Wide Bands Range Expansion 0.74%
    Doji - Bearish? Reversal -1.91%
    Wide Bands Range Expansion -1.91%
    Gapped Up Strength -1.91%
    Up 3 Days in a Row Strength -1.91%
    Older End-of-Day Signals for AUTL ...

       Recent Intraday Alerts

    Alert Time
    1.5x Volume Pace about 21 hours ago
    Rose Above Previous Day's High about 22 hours ago
    Outside Day about 22 hours ago
    Up 3% about 22 hours ago
    Up 2% about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    AUTL Chart by TradingView
    Basic chart:

    Profile

    Autolus Therapeutics Ltd is a biopharmaceutical company. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer. The company's pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and AUTO6.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Treatment Of Cancer

    Is AUTL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 Recent 13% pullback isn't enough to hurt long-term Autolus Therapeutics (NASDAQ:AUTL) shareholders, they're still up 157% over 1 year
    Apr 24 Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
    Apr 23 Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
    Apr 2 Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B...
    Mar 21 Q4 2023 BioNTech SE Earnings Call
    Mar 17 Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2023 Earnings Call Transcript
    Mar 15 Autolus Therapeutics Full Year 2023 Earnings: EPS Misses Expectations
    Mar 15 Q4 2023 Autolus Therapeutics PLC Earnings Call
    Mar 15 Autolus Therapeutics plc (AUTL) Q4 2023 Earnings Call Transcript
    Mar 14 Autolus Therapeutics PLC Reports Full Year 2023 Financial Results
    See more AUTL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.45
    52 Week Low 1.79
    Average Volume 1,586,134
    200-Day Moving Average 4.46
    50-Day Moving Average 5.24
    20-Day Moving Average 4.38
    10-Day Moving Average 4.01
    Average True Range 0.31
    RSI (14) 36.71
    ADX 23.77
    +DI 16.79
    -DI 23.98
    Chandelier Exit (Long, 3 ATRs) 4.60
    Chandelier Exit (Short, 3 ATRs) 4.55
    Upper Bollinger Bands 5.26
    Lower Bollinger Band 3.50
    Percent B (%b) 0.35
    BandWidth 40.37
    MACD Line -0.39
    MACD Signal Line -0.42
    MACD Histogram 0.0338
    Fundamentals Value
    Market Cap 715.09 Million
    Num Shares 174 Million
    EPS -0.98
    Price-to-Earnings (P/E) Ratio -4.19
    Price-to-Sales 200.99
    Price-to-Book 6.15
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.50
    Resistance 3 (R3) 4.49 4.34 4.43
    Resistance 2 (R2) 4.34 4.24 4.35 4.41
    Resistance 1 (R1) 4.23 4.18 4.28 4.24 4.39
    Pivot Point 4.08 4.08 4.11 4.09 4.08
    Support 1 (S1) 3.97 3.98 4.03 3.98 3.83
    Support 2 (S2) 3.82 3.92 3.83 3.81
    Support 3 (S3) 3.71 3.82 3.79
    Support 4 (S4) 3.72